Recognition of an MHC class I-restricted antigenic peptide can be modulated by para-substitution of its buried tyrosine residues in a TCR- specific manner

Journal of Immunology

Volumn 162, Issue 10, 1999, Pages 5998-6008

  Saito, Naoyuki G ^a   Chang, Hsiu Ching ^b   Paterson, Yvonne ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(4 BROMOPHENYL)ALANINE; 4 FLUOROPHENYLALANINE; EPITOPE; H2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; PHENYLALANINE; PHENYLALANINE DERIVATIVE; T LYMPHOCYTE RECEPTOR; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS;

ANIMALS; ANTIGENS, VIRAL; COMPUTER SIMULATION; FEMALE; H-2 ANTIGENS; MICE; MICE, INBRED C57BL; MODELS, MOLECULAR; NUCLEOCAPSID; NUCLEOCAPSID PROTEINS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; TYROSINE;

EID: 0033563220     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329:512.
2. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506.
3. Saper, M. A., P. J. Bjorkman, and D. C. Wiley. 1991. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J. Mol. Biol. 219:277.
4. Falk, K., O. Rötzschke, S. Stevanović., G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
5. b binding motif. J. Immunol. 150:1212.
6. d serologic recognition. J. Immunol. 151: 5387.
7. Solheim, J. C., B. M. Carreno, N. B. Myers, D. R. Lee, and T. H. Hansen. 1995. Peptide-induced rescue of serologic epitopes on class I MHC molecules. J. Immunol. 154:1188.
8. Smith, K. D., Z. B. Kurago, and C. T. Lutz. 1997. Conformational changes in MHC class I molecules: antibody, T-cell receptor, and NK cell recognition in an HLA-B7 model system. Immunol. Res. 16:243.
9. Rohren, E. M., D. J. McCormick, and L. R. Pease. 1994. Peptide-induced conformational changes in class I molecules: direct detection by flow cytometry. J. Immunol. 152:5337.
10. Pease, L. R., R. M. Horton, J. K. Pullen, H. D. Hunt, T. J. Yun, E. M. Rohren, J. L. Prescott, S. M. Jobe, and K. S. Allen. 1993. Amino acid changes in the peptide binding site have structural consequences at the surface of class I glycoproteins. J. Immunol. 150:3375.
11. Catipović, B., J. Dal Porto, M. Mage, T. E. Johansen, and J. P. Schneck. 1992. Major histocompatibility complex conformational epitopes are peptide specific. J. Exp. Med. 176:1611.
12. Elliott, T., V. Cerundolo, J. Elvin, and A. Townsend. 1991. Peptide-induced conformational change of the class I heavy chain. Nature 351:402.
13. Chen, W., J. Fecondo, and J. McCluskey. 1994. The structural influence of individual residues located within peptide antigen depends upon their sequence context. Mol. Immunol. 31:1069.
14. Bluestone, J. A., S. Jameson, S. Miller, and R. Dick, Jr. 1992. Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition. J. Exp. Med. 176:1757.
15. Bluestone, J. A., A. Kaliyaperumal, S. Jameson, S. Miller, and R. Dick, Jr. 1993. Peptide-induced changes in class I heavy chains alter allorecognition. J. Immunol. 151:3943.
16. Chattopadhyay, S., M. Theobald, J. Biggs, and L. A. Sherman. 1994. Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity. J. Exp. Med. 179:213.
17. Chen, W., J. McCluskey, S. Rodda, and F. R. Carbone. 1993. Changes at peptide residues buried in the major histocompatibility complex (MHC) class I binding cleft influence T cell recognition: a possible role for indirect conformational alterations in the MHC class I or bound peptide in determining T cell recognition. J. Exp. Med. 177:869.
18. Merrifield, T. B. 1963. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:2149.
19. b molecule. Nature 348:213.
20. Carbone, F. R., and M. J. Bevan. 1989. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J. Exp. Med. 169:603.
21. Gorer, P. A. 1950. Studies in antibody response of mice to tumour inoculation. Br. J. Cancer 4:372.
22. Puddington, L., M. J. Bevan, J. K. Rose, and L. Lefrancois. 1986. N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells. J. Virol. 60:708.
23. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777.
24. Dunn, T. B., and M. Potter. 1957. A transplantable mast-cell neoplasm in the mouse. J. Natl. Cancer Inst. 18:587.
25. Ljunggren, H. G., and K. Kärre. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162: 1745.
26. 2-microglobulin observed in cells with increased sensitivity to NK cell lysis. J. Immunol. 142: 2911.
27. Attaya, M., S. Jameson, C. K. Martinez, E. Hermel, C. Aldrich, J. Forman, K. F. Lindahl, M. J. Bevan, and J. J. Monaco. 1992. Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 355:647.
28. Yang, Y., K. Früh, J. Chambers, J. B. Waters, L. Wu, T. Spies, and P. A. Peterson. 1992. Major histocompatibility complex (MHC)-encoded HAM2 is necessary for antigenic peptide loading onto class I MHC molecules. J. Biol. Chem. 267:11669.
29. Ossevoort, M. A., A. J. Sijts, K. J. van Veen, F. Momburg, G. J. Hämmerling, A. Seelig, G. W. Butcher, J. C. Howard, W. M. Kast, and C. J. Melief. 1993. Differential effect of transporter Tap 2 gene introduction into RMA-S cells on viral antigen processing. Eur. J. Immunol. 23:3082.
30. Hagiya, M., D. D. Davis, T. Takahashi, K. Okuda, W. C. Raschke, and H, Sakano. 1986. Two types of immunoglobulin-negative Abelson murine leukemia virus-transformed cells: implications for B-lymphocyte differentiation. Proc. Natl. Acad. Sci. USA 83:145.
31. b-restricted anti-vesicular stomatitis vims and alloreactive cytotoxic T cells. J. Immunol. 138:3654-60.
32. b-restricted ovalbumin determinant. Eur. J. Immunol. 20:2431.
33. b class I molecule. Cell. Immunol. 160:33.
34. b molecule by the side chains of three amino acids and the main-chain atoms of the amino terminus. Proc. Natl. Acad. Sci. USA 89:3135.
35. Letoumeur, F., and B. Malissen. 1989. Derivation of a T cell hybridoma variant deprived of functional T cell receptor α and β chain transcripts reveals a non-functional α-mRNA of BW5147 origin. Eur. J. Immunol. 19:2269.
36. Chang, H. C., A. Smolyar, R. Spoerl, T. Witte, Y. Yao, E. C. Goyarts, S. G. Nathenson, and E. L. Reinherz. 1997. Topology of T cell receptor-peptide/ class I MHC interaction defined by charge reversal complementation and functional analysis. J. Mol. Biol. 271:278.
37. b complex. Eur. J. Immunol. 27:227.
38. Ozato, K., N. M. Mayer, and D. H. Sachs. 1982. Monoclonal antibodies to mouse major histocompatibility complex antigens. Transplantation 34:113.
39. b haplotype reveal genetic control of isotype expression. J. Immunol. 126:317.
40. Jones, B., and C. A. Janeway, Jr. 1981. Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted. Nature 292:547.
41. b mutants. Immunogenetics 12:183.
42. b somatic cell variants. J. Immunol. 137:1239.
43. Tada, N., S. Kimura, A. Hatzfeld, and U. Hämmerling. 1980. Ly-m11: the H-3 region of mouse chromosome 2 controls a new surface alloantigen. Immunogenetics 11:441.
44. b antigens determined with monoclonal antibodies and H-2 mutant mice. Proc. Natl. Acad. Sci. USA 79:4737.
45. Wunderlich, J., and G. Shearer. 1991. Assays for T cell function. In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. J. Margulies, E. M. Shevach, and W. Strober, eds. Greene Publishing and Wiley-Interscience, New York, p. 3.11.1.
46. Ljunggren, H. G., N. J. Stam, C. Öhlén, J. J. Neefjes, P. Höglund, M. T. Heemels, J. Bastin, T. N. Schumacher, A. Townsend, K. Kärre, and H. L. Ploegh. 1990. Empty MHC class I molecules come out in the cold. Nature 346:476.
47. Hogquist, K. A., A. G. Grandea III, and M. J. Bevan. 1993. Peptide variants reveal how antibodies recognize major histocompatibility complex class I. Eur. J. Immunol. 23:3028.
48. Gillis, S., and K. A. Smith. 1977. In vitro generation of tumor-specific cytotoxic lymphocytes: secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells. J. Exp. Med. 146:468.
49. Gillis, S., and K. A. Smith. 1977. Long term culture of tumour-specific cytotoxic T cells. Nature 268:154.
50. Gillis, S., M. M. Ferm, W. Ou, and K. A. Smith. 1978. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027.
51. b. Science 257:919.
52. Abola, E. E., J. L. Sussman, J. Prilusky, and N. O. Manning. 1997. Protein Data Bank archives of three-dimensional macromolecular structures. In Methods in Enzymology, Vol. 277. C. W. Carter, Jr., and R. M. Sweet, eds. Academic Press, San Diego, p. 556.
53. Abola, E. E., F. C. Bernstein, S. H. Bryant, T. F. Koetzle, and J. Weng. 1987. Protein Data Bank. In Data Commission of the International Union of Crystallography, F. H. Allen, G. Bergerhoff, and R. Sievers, eds., Bonn, p. 107.
54. Dauber-Osguthorpe, P., V. A. Roberts, D. J. Osguthorpe, J. Wolff, M. Genest, and A. T. Hagler. 1988. Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase-trimethoprim, a drug-receptor system. Proteins 4:31.
55. Feltkamp, M. C., M. P. Vierboom, R. E. Toes, F. Ossendorp, J. ter Schegget, C. J. Melief, and W. M. Kast. 1995. Competition inhibition of cytotoxic T-lymphocyte (CTL) lysis, a more sensitive method to identify candidate CTL epitopes than induction of antibody-detected MHC class I stabilization. Immunol. Lett. 47:1.
56. Ajitkumar, P., S. S. Geier, K. V. Kesari, F. Borriello, M. Nakagawa, J. A. Bluestone, M. A. Saper, D. C. Wiley, and S. G. Nathenson. 1988. Evidence that multiple residues on both the α-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor. Cell 54:47.
57. Bluestone, J. A., I. F. McKenzie, R. W. Melvold, K. Ozato, M. S. Sandrin, S. O. Sharrow, and D. H. Sachs. 1984. Serological analysis of H-2 mutations using monoclonal antibodies. J. Immunogenet. 11:197.
58. 2-microglobulin b is inducible with peptide-ligand. Transplantation 59:124.
59. b molecule. Immunity 3:573.
60. Teng, M. K., A. Smolyar, A. G. D. Tse, J. H. Liu, J. Liu, R. E. Hussey, S. G. Nathenson, H. C. Chang, E. L. Reinherz, and J. H. Wang. 1998. Identification of a common docking topology with substantial variation among different TCR-peptide-MHC complexes. Curr. Biol. 8:409.
61. d. FEBS Lett. 317:49.
62. Saito, Y., P. A. Peterson, and M. Matsumura. 1993. Quantitation of peptide anchor residue contributions to class I major histocompatibility complex molecule binding. J. Biol. Chem. 268:21309.
63. Neefjes, J. J., J. Dierx, and H. L. Ploegh. 1993. The effect of anchor residue modifications on the stability of major histocompatibility complex class I-peptide interactions. Eur. J. Immunol. 23:840.
64. Deres, K., W. Beck, S. Faath, G. Jung, and H. G. Rammensee. 1993. MHC/ peptide binding studies indicate hierarchy of anchor residues. Cell. Immunol. 151:158.
65. Smith, K. J., S. W. Reid, D. I. Stuart, A. J. McMichael, E. Y. Jones, and J. I. Bell. 1996. An altered position of the α2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 4:203.
66. Bouvier, M., and D. C. Wiley. 1998. Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/β2m heterodimer. Nat. Struct. Biol. 5:377.
67. b upon peptide binding. Biochemistry 37:3001.
68. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.
69. Dong, T., D. Boyd, W. Rosenberg, N. Alp, M. Takiguchi, A. McMichael, and S. Rowland-Jones. 1996. An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide. Eur. J. Immunol. 26:335.
70. Jameson, S. C., F. R. Carbone, and M. J. Bevan. 1993. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177:1541.
71. Reid, S. W., S. McAdam, K. J. Smith, P. Klenerman, C. A. O'Callaghan, K. Harlos, B. K. Jakobsen, A. J. McMichael, J. I. Bell, D. I. Stuart, and E. Y. Jones. 1996. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J. Exp. Med. 184:2279.
72. Nose, T., Y. Shimohigashi, M. Ohno, T. Costa, N. Shimizu, and Y. Ogino. 1993. Enhancement of thrombin receptor activation by thrombin receptor-derived heptapeptide with para-fluorophenylalanine in place of phenylalanine. Biochem. Biophys. Res. Commun. 193:694.
73. Ippolito, J. A., and D. W. Christianson. 1992. The contribution of halogen atoms to protein-ligand interactions. Int. J. Biol. Macromol. 14:193.
74. Tourdot, S., M. Oukka, J. C. Manuguerra, V. Magafa, I. Vergnon, N. Riche, M. Bruley-Rosset, P. Cordopatis, and K. Kosmatopoulos. 1997. Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination. J. Immunol. 159:2391.
75. Matsumura, M., D. H. Fremont, P. A. Peterson, and I. A. Wilson. 1992. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257:927.
76. Saito, N. G., and Y. Paterson. 1997. Contribution of peptide backbone atoms to binding of an antigenic peptide to class I major histocompatibility molecule. Mol. Immunol. 34:1133.
77. b molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. Proc. Natl. Acad. Sci. USA 89:8403.
78. b-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl. Acad. Sci. USA 92:2479.
79. Sherman, L. A., S. Chattopadhyay, J. A. Biggs, R. F. Dick, Jr., and J. A. Bluestone. 1993. Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides. Proc. Natl. Acad. Sci. USA 90:6949.
80. Ding, Y. H., K. J. Smith, D. N. Garboczi, U. Utz, W. E. Biddison, and D. C. Wiley. 1998. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 8:403.
81. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134.
82. Dressel, A., J. L. Chin, A. Sette, R. Gausling, P. Höllsberg, and D. A. Hafler. 1997. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands. J. Immunol. 159:4943.
83. Zaremba, S., E. Barzaga, M. Zhu, N. Soares, K. Y. Tsang, and J. Schlom. 1997. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen. Cancer Res. 57:4570.
84. Nicholson, L. B., H. Waldner, A. M. Carrizosa, A. Sette, M. Collins, and V. K. Kuchroo. 1998. Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity. Proc. Natl. Acad. Sci. USA 95:264.
85. Rogers, P. R., H. M. Grey, and M. Croft. 1998. Modulation of naive CD4 T cell activation with altered peptide ligands: the nature of the peptide and presentation in the context of costimulation are critical for a sustained response. J. Immunol. 160:3698.
86. Rammensee, H. G., T. Friede, and S. Stevanović. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.